Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Total Current Liabilities (2023 - 2026)

Translational Development Acquisition's Total Current Liabilities history spans 4 years, with the latest figure at $861085.0 for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 166.67% to $861085.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $861085.0, a 166.67% increase, with the full-year FY2025 number at $544073.0, up 158.71% from a year prior.
  • Total Current Liabilities came in at $861085.0 for Q1 2026, up from $544073.0 in the prior quarter.
  • The five-year high for Total Current Liabilities was $861085.0 in Q1 2026, with the low at $210303.0 in Q4 2024.
  • Historically, Total Current Liabilities has averaged $450795.3 across 4 years, with a median of $422845.0 in 2025.
  • Biggest five-year swings in Total Current Liabilities: plummeted 58.74% in 2024 and later surged 166.67% in 2026.
  • Year by year, Total Current Liabilities stood at $509679.0 in 2023, then crashed by 58.74% to $210303.0 in 2024, then soared by 158.71% to $544073.0 in 2025, then surged by 58.27% to $861085.0 in 2026.
  • Business Quant data shows Total Current Liabilities for TDAC at $861085.0 in Q1 2026, $544073.0 in Q4 2025, and $422845.0 in Q3 2025.